"Cripps Advises Bedfont Scientific on Majority Stake Sale to Keensight Capital"

"Cripps has successfully advised the shareholders of Bedfont Scientific Limited on the sale of a majority stake to Keensight Capital, a prominent European private equity firm. Bedfont, established in 1976 and based in Kent, specializes in breath analysis and gas monitoring devices used in healthcare and industry. This significant transaction aims to enhance Bedfont's global growth and innovation. The Cripps team showcased their expertise in managing complex cross-border private equity deals, with support from EC M&A and legal advisers Paul Hastings for Keensight Capital."

Cripps and Paul Hastings participated in the transaction, advising the shareholders of Bedfont Scientific Limited and Keensight Capital, respectively. The transaction involved the sale of a majority stake in Bedfont Scientific Limited, a company specializing in breath analysis and gas monitoring devices, to Keensight Capital, a prominent European private equity firm. This significant deal is expected to accelerate Bedfont's global growth and innovation in the healthcare sector. The Cripps team included the following lawyers: John Kirkwood (Corporate Partner), Victoria Symons, Freddie Pawlik, Lawrence Moran, Jack Broadley, Paul Maudgil, Kat Rogers, Aimee Mitchell, Emma Saunders, and Paul Fairbairn. Paul Hastings acted as legal advisers to Keensight Capital. Corporate finance advice to the sellers was provided by EC M&A.

"Cripps Advises Bedfont Scientific on Majority Stake Sale to Keensight Capital"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads